Approval · Notice of Compliance 5508 · 1994
ZOLOFT: Notice of Compliance 5508
Issued September 27, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5508
- Date
- September 27, 1994
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLOFT | 02132702 | Marketed |
Medicinal ingredients
- SERTRALINE HYDROCHLORIDE 25 MG per CAP